EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Given Consensus Recommendation of “Buy” by Analysts

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report) has been given an average rating of “Buy” by the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and two have assigned a strong buy recommendation to the company.

Separately, Deutsche Bank Aktiengesellschaft started coverage on EssilorLuxottica in a research note on Tuesday, May 12th. They set a “hold” rating on the stock.

Check Out Our Latest Analysis on ESLOY

EssilorLuxottica Stock Down 3.3%

Shares of OTCMKTS:ESLOY opened at $99.31 on Friday. The company has a quick ratio of 0.70, a current ratio of 0.99 and a debt-to-equity ratio of 0.17. The business’s 50 day moving average price is $107.94 and its 200-day moving average price is $136.89. EssilorLuxottica has a 1 year low of $96.56 and a 1 year high of $186.81.

EssilorLuxottica Company Profile

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Featured Stories

Analyst Recommendations for EssilorLuxottica (OTCMKTS:ESLOY)

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.